Dapiprazole
Chemical compound
- B
administration
- S01EX02 (WHO)
- In general: ℞ (Prescription only)
- 3-{2-[4-(2-methylphenyl)piperazin-1-yl]ethyl}-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,5-a]pyridine
- 72822-12-9
Y
- 3033538
- 7155
- DB00298 Y
- 2298190 Y
- 5RNZ8GJO7K
- D07775 Y
- CHEBI:51066 Y
- ChEMBL1201216
N
- DTXSID90223140
- Interactive image
- n1nc(n2c1CCCC2)CCN4CCN(c3ccccc3C)CC4
- InChI=1S/C19H27N5/c1-16-6-2-3-7-17(16)23-14-12-22(13-15-23)11-9-19-21-20-18-8-4-5-10-24(18)19/h2-3,6-7H,4-5,8-15H2,1H3Y
- Key:RFWZESUMWJKKRN-UHFFFAOYSA-NY
N
Y (what is this?) (verify)Dapiprazole (brand name Rev-Eyes) is an alpha-1 blocker. It is used to reverse mydriasis after eye examination.[1]
References
- ^ Doughty MJ, Lyle WM (May 1992). "A review of the clinical pharmacokinetics of pilocarpine, moxisylyte (thymoxamine), and dapiprazole in the reversal of diagnostic pupillary dilation". Optometry and Vision Science. 69 (5): 358–68. doi:10.1097/00006324-199205000-00005. PMID 1350669. S2CID 22781280.
- v
- t
- e
- Apraclonidine
- Brimonidine (+timolol)
- Clonidine
- Dipivefrine
- Epinephrine
| muscarinic | |
|---|---|
| muscarinic/nicotinic | |
| acetylcholinesterase inhibitors |
(sulfonamides)
- Dapiprazole
- Guanethidine
- Netarsudil (+latanoprost)
- Omidenepag
- Ripasudil
 | This antihypertensive-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
